Detalles de la búsqueda
1.
An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.
Int J Mol Sci
; 24(24)2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38139063
2.
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.
Int J Mol Sci
; 23(10)2022 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628616
3.
Process to Remove the Size Variants Contained in the Antibody-Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.
Pharmaceuticals (Basel)
; 16(10)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37895812
4.
Trace Metal Impurities Effects on the Formation of [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM).
Pharmaceuticals (Basel)
; 17(1)2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38275997
5.
Identification and quantitative structure-activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM.
Nucl Med Biol
; 108-109: 10-15, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35168008
6.
Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with 64Cu-labeled cetuximab against peritoneal dissemination of gastric cancer in a mouse model.
J Cancer Res Ther
; 18(4): 907-914, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149139
7.
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
Pharmaceutics
; 14(9)2022 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36145676
8.
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.
Pharmaceutics
; 13(10)2021 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34683999
9.
Characterization and Stabilization of a New 64Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography.
Pharmaceutics
; 14(1)2021 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35056963
10.
Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates.
Pharmaceuticals (Basel)
; 14(10)2021 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681174
11.
Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.
Nucl Med Commun
; 42(10): 1112-1121, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100794
12.
Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.
Sci Rep
; 10(1): 4143, 2020 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157106
Resultados
1 -
12
de 12
1
Próxima >
>>